Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Interest & Investment Income (2016 - 2020)

Prestige Consumer Healthcare has reported Interest & Investment Income over the past 10 years, most recently at $24000.0 for Q2 2020.

  • For Q2 2020, Interest & Investment Income fell 44.19% year-over-year to $24000.0; the TTM value through Jun 2020 reached $323000.0, up 101.87%, while the annual FY2020 figure was $342000.0, 57.6% up from the prior year.
  • Interest & Investment Income for Q2 2020 was $24000.0 at Prestige Consumer Healthcare, up from $22000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $245000.0 in Q4 2019 and troughed at $22000.0 in Q1 2020.
  • A 5-year average of $69166.7 and a median of $50000.0 in 2016 define the central range for Interest & Investment Income.
  • Biggest five-year swings in Interest & Investment Income: tumbled 67.23% in 2018 and later surged 528.21% in 2019.
  • Year by year, Interest & Investment Income stood at $46000.0 in 2016, then surged by 158.7% to $119000.0 in 2017, then tumbled by 67.23% to $39000.0 in 2018, then surged by 528.21% to $245000.0 in 2019, then tumbled by 90.2% to $24000.0 in 2020.
  • Business Quant data shows Interest & Investment Income for PBH at $24000.0 in Q2 2020, $22000.0 in Q1 2020, and $245000.0 in Q4 2019.